FLONASE ALLERGY RELIEF is a Nasal Spray, Metered in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Fluticasone Propionate.
Product ID | 0135-0576_1f0c6c8a-8452-45ae-8ed6-517e855d70b9 |
NDC | 0135-0576 |
Product Type | Human Otc Drug |
Proprietary Name | FLONASE ALLERGY RELIEF |
Generic Name | Fluticasone Propionate |
Dosage Form | Spray, Metered |
Route of Administration | NASAL |
Marketing Start Date | 2014-12-04 |
Marketing Category | NDA / NDA |
Application Number | NDA205434 |
Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
Substance Name | FLUTICASONE PROPIONATE |
Active Ingredient Strength | 50 ug/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2016-06-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA205434 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-12-04 |
Marketing Category | NDA |
Application Number | NDA205434 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-01-07 |
Marketing Category | NDA |
Application Number | NDA205434 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-03-20 |
Marketing Category | NDA |
Application Number | NDA205434 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-02-29 |
Marketing Category | NDA |
Application Number | NDA205434 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2016-06-30 |
Marketing Category | NDA |
Application Number | NDA205434 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2014-12-04 |
Marketing Category | NDA |
Application Number | NDA205434 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-03-20 |
Marketing Category | NDA |
Application Number | NDA205434 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2016-11-17 |
Marketing Category | NDA |
Application Number | NDA205434 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-01-22 |
Ingredient | Strength |
---|---|
FLUTICASONE PROPIONATE | 50 ug/1 |
SPL SET ID: | b6134ba0-b70a-4eac-9a82-cef64b242c1d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
70518-1223 | FLONASE ALLERGY RELIEF | FLONASE ALLERGY RELIEF |
50090-1978 | FLONASE ALLERGY RELIEF | FLONASE ALLERGY RELIEF |
0113-7117 | basic care allergy relief nasal | Fluticasone propionate |
0135-0582 | CHILDRENS FLONASE | fluticasone propionate |
0135-0576 | FLONASE | fluticasone propionate |
0173-0600 | FLOVENT | fluticasone propionate |
0173-0601 | FLOVENT | fluticasone propionate |
0173-0602 | FLOVENT | fluticasone propionate |
0173-0718 | FLOVENT | fluticasone propionate |
0054-3270 | Fluticasone Propionate | Fluticasone Propionate |
0168-0332 | FLUTICASONE PROPIONATE | fluticasone propionate |
0168-0333 | Fluticasone Propionate | fluticasone propionate |
0168-0434 | FLUTICASONE PROPIONATE | fluticasone propionate |
0113-0028 | Good Sense 24 hour allergy nasal | Fluticasone propionate |
0113-0285 | Good Sense 24 hour allergy nasal | Fluticasone Propionate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FLONASE 97701366 not registered Live/Pending |
GlaxoSmithKline Consumer Healthcare (UK) IP Limited 2022-12-02 |
FLONASE 97121742 not registered Live/Pending |
Glaxo Group Limited 2021-11-12 |
FLONASE 86746149 4959825 Live/Registered |
Glaxo Group Limited 2015-09-02 |
FLONASE 85958560 4809013 Live/Registered |
Glaxo Group Limited 2013-06-13 |
FLONASE 74389190 1870977 Live/Registered |
GLAXO GROUP LIMITED 1993-05-11 |
FLONASE 74109574 not registered Dead/Abandoned |
GLAXO GROUP LIMITED 1990-10-26 |